Header Logo

Connection

ZOANN DREYER to Humans

Back to Details
This is a "connection" page, showing publications ZOANN DREYER has written about Humans.
ZOANN DREYER
Connection Strength
0.154
Humans
  1. Philadelphia chromosome-positive pre-B lymphoblastic leukemia presenting as acute hepatic failure in a pediatric patient. Pediatr Hematol Oncol. 2022 08; 39(5):481-487.
    View in: PubMed
    Score: 0.016
  2. 50 Years Ago in The Journal of Pediatrics: Prevention and Management of Acute Hyperuricemia in Childhood Leukemia. J Pediatr. 2017 12; 191:178.
    View in: PubMed
    Score: 0.012
  3. Intensified chemotherapy without SCT in infant ALL: results from COG P9407 (Cohort 3). Pediatr Blood Cancer. 2015 Mar; 62(3):419-26.
    View in: PubMed
    Score: 0.010
  4. Modifications to induction therapy decrease risk of early death in infants with acute lymphoblastic leukemia treated on Children's Oncology Group P9407. Pediatr Blood Cancer. 2012 Nov; 59(5):834-9.
    View in: PubMed
    Score: 0.008
  5. Analysis of the role of hematopoietic stem-cell transplantation in infants with acute lymphoblastic leukemia in first remission and MLL gene rearrangements: a report from the Children's Oncology Group. J Clin Oncol. 2011 Jan 10; 29(2):214-22.
    View in: PubMed
    Score: 0.007
  6. Phase 2 study of idarubicin in pediatric brain tumors: Pediatric Oncology Group study POG 9237. Neuro Oncol. 2003 Oct; 5(4):261-7.
    View in: PubMed
    Score: 0.004
  7. Outstanding outcomes in infants with KMT2A-germline acute lymphoblastic leukemia treated with chemotherapy alone: results of the Children's Oncology Group AALL0631 trial. Haematologica. 2022 05 01; 107(5):1205-1208.
    View in: PubMed
    Score: 0.004
  8. Pneumonia in the immunocompromised pediatric cancer patient. Semin Respir Infect. 2002 Mar; 17(1):21-32.
    View in: PubMed
    Score: 0.004
  9. Scoliosis in Children Treated With Photon Craniospinal Irradiation for Medulloblastoma. Int J Radiat Oncol Biol Phys. 2021 03 01; 109(3):712-717.
    View in: PubMed
    Score: 0.004
  10. FLT3 inhibitor lestaurtinib plus chemotherapy for newly diagnosed KMT2A-rearranged infant acute lymphoblastic leukemia: Children's Oncology Group trial AALL0631. Leukemia. 2021 05; 35(5):1279-1290.
    View in: PubMed
    Score: 0.004
  11. Association of GSTM1 null variant with anthracycline-related cardiomyopathy after childhood cancer-A Children's Oncology Group ALTE03N1 report. Cancer. 2020 09 01; 126(17):4051-4058.
    View in: PubMed
    Score: 0.003
  12. Early Lifestyle Intervention for Obesity Prevention in Pediatric Survivors of Acute Lymphoblastic Leukemia. Nutrients. 2019 Nov 02; 11(11).
    View in: PubMed
    Score: 0.003
  13. The Population Pharmacokinetics of High-Dose Methotrexate in Infants with Acute Lymphoblastic Leukemia Highlight the Need for Bedside Individualized Dose Adjustment: A Report from the Children's Oncology Group. Clin Pharmacokinet. 2019 07; 58(7):899-910.
    View in: PubMed
    Score: 0.003
  14. Hypothyroidism after craniospinal irradiation with proton or photon therapy in patients with medulloblastoma. Pediatr Hematol Oncol. 2018 May; 35(4):257-267.
    View in: PubMed
    Score: 0.003
  15. Targeting EIF4E signaling with ribavirin in infant acute lymphoblastic leukemia. Oncogene. 2019 03; 38(13):2241-2262.
    View in: PubMed
    Score: 0.003
  16. Disparities in Neurotoxicity Risk and Outcomes among Pediatric Acute Lymphoblastic Leukemia Patients. Clin Cancer Res. 2018 10 15; 24(20):5012-5017.
    View in: PubMed
    Score: 0.003
  17. Outcome of pediatric patients with acute lymphoblastic leukemia/lymphoblastic lymphoma with hypersensitivity to pegaspargase treated with PEGylated Erwinia asparaginase, pegcrisantaspase: A report from the Children's Oncology Group. Pediatr Blood Cancer. 2018 03; 65(3).
    View in: PubMed
    Score: 0.003
  18. Predictors of Suboptimal Follow-up in Pediatric Cancer Survivors. J Pediatr Hematol Oncol. 2017 04; 39(3):e143-e149.
    View in: PubMed
    Score: 0.003
  19. Deliberate liver transplantation for fulminant liver failure with acute lymphoblastic leukemia. Liver Transpl. 2016 12; 22(12):1724-1726.
    View in: PubMed
    Score: 0.003
  20. A Pilot Study of Intensified PEG-Asparaginase in High-risk Acute Lymphoblastic Leukemia: Children's Oncology Group Study AALL08P1. J Pediatr Hematol Oncol. 2016 08; 38(6):409-17.
    View in: PubMed
    Score: 0.003
  21. CELF4 Variant and Anthracycline-Related Cardiomyopathy: A Children's Oncology Group Genome-Wide Association Study. J Clin Oncol. 2016 Mar 10; 34(8):863-70.
    View in: PubMed
    Score: 0.003
  22. Activity and Toxicity of Intravenous Erwinia Asparaginase Following Allergy to E. coli-Derived Asparaginase in Children and Adolescents With Acute Lymphoblastic Leukemia. Pediatr Blood Cancer. 2016 Feb; 63(2):228-33.
    View in: PubMed
    Score: 0.003
  23. Adult Low-Hypodiploid Acute B-Lymphoblastic Leukemia With IKZF3 Deletion and TP53 Mutation: Comparison With Pediatric Patients. Am J Clin Pathol. 2015 Aug; 144(2):263-70.
    View in: PubMed
    Score: 0.003
  24. Decreased induction morbidity and mortality following modification to induction therapy in infants with acute lymphoblastic leukemia enrolled on AALL0631: a report from the Children's Oncology Group. Pediatr Blood Cancer. 2015 Mar; 62(3):414-8.
    View in: PubMed
    Score: 0.002
  25. Hyaluronan synthase 3 variant and anthracycline-related cardiomyopathy: a report from the children's oncology group. J Clin Oncol. 2014 Mar 01; 32(7):647-53.
    View in: PubMed
    Score: 0.002
  26. Safety profile of asparaginase Erwinia chrysanthemi in a large compassionate-use trial. Pediatr Blood Cancer. 2014 Jul; 61(7):1232-8.
    View in: PubMed
    Score: 0.002
  27. Granulocyte transfusions for children with infection and neutropenia or granulocyte dysfunction. Pediatr Hematol Oncol. 2014 Aug; 31(5):425-34.
    View in: PubMed
    Score: 0.002
  28. Potent obatoclax cytotoxicity and activation of triple death mode killing across infant acute lymphoblastic leukemia. Blood. 2013 Apr 04; 121(14):2689-703.
    View in: PubMed
    Score: 0.002
  29. Identification of TP53 as an acute lymphocytic leukemia susceptibility gene through exome sequencing. Pediatr Blood Cancer. 2013 Jun; 60(6):E1-3.
    View in: PubMed
    Score: 0.002
  30. Human papillomavirus vaccination in female pediatric cancer survivors. J Pediatr Adolesc Gynecol. 2012 Oct; 25(5):305-7.
    View in: PubMed
    Score: 0.002
  31. Gene expression profiles predictive of outcome and age in infant acute lymphoblastic leukemia: a Children's Oncology Group study. Blood. 2012 Feb 23; 119(8):1872-81.
    View in: PubMed
    Score: 0.002
  32. Clinical cancer advances 2011: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology. J Clin Oncol. 2012 Jan 01; 30(1):88-109.
    View in: PubMed
    Score: 0.002
  33. Impact of PET-CT on involved field radiotherapy design for pediatric Hodgkin lymphoma. Pediatr Blood Cancer. 2012 Jun; 58(6):860-4.
    View in: PubMed
    Score: 0.002
  34. Folate pathway polymorphisms predict deficits in attention and processing speed after childhood leukemia therapy. Pediatr Blood Cancer. 2011 Sep; 57(3):454-60.
    View in: PubMed
    Score: 0.002
  35. A meta-analysis of MTHFR C677T and A1298C polymorphisms and risk of acute lymphoblastic leukemia in children. Pediatr Blood Cancer. 2012 Apr; 58(4):513-8.
    View in: PubMed
    Score: 0.002
  36. Height impairment after lower dose cranial irradiation in children with acute lymphoblastic leukemia. Pediatr Blood Cancer. 2011 Feb; 56(2):279-81.
    View in: PubMed
    Score: 0.002
  37. Molecular monitoring of 8p11 myeloproliferative syndrome in an infant. J Pediatr Hematol Oncol. 2009 Nov; 31(11):879-83.
    View in: PubMed
    Score: 0.002
  38. Overexpression of ZNF342 by juxtaposition with MPO promoter/enhancer in the novel translocation t(17;19)(q23;q13.32) in pediatric acute myeloid leukemia and analysis of ZNF342 expression in leukemia. Genes Chromosomes Cancer. 2009 Jun; 48(6):480-9.
    View in: PubMed
    Score: 0.002
  39. Analysis of infectious complications in infants with acute lymphoblastic leukemia treated on the Children's Cancer Group Protocol 1953: a report from the Children's Oncology Group. J Pediatr Hematol Oncol. 2009 Jun; 31(6):398-405.
    View in: PubMed
    Score: 0.002
  40. Screening for neurocognitive impairment in pediatric cancer long-term survivors. J Clin Oncol. 2008 Sep 01; 26(25):4138-43.
    View in: PubMed
    Score: 0.002
  41. Folate pathway genetic polymorphisms are related to attention disorders in childhood leukemia survivors. J Pediatr. 2008 Jan; 152(1):101-5.
    View in: PubMed
    Score: 0.001
  42. Staged single-ventricle palliation in an infant with hemoglobin SC disease. Tex Heart Inst J. 2007; 34(4):439-41.
    View in: PubMed
    Score: 0.001
  43. Methotrexate pharmacokinetics in infants with acute lymphoblastic leukemia. Cancer Chemother Pharmacol. 2007 May; 59(6):847-53.
    View in: PubMed
    Score: 0.001
  44. Analysis of prognostic factors of acute lymphoblastic leukemia in infants: report on CCG 1953 from the Children's Oncology Group. Blood. 2006 Jul 15; 108(2):441-51.
    View in: PubMed
    Score: 0.001
  45. Conservative surgical treatment of a profoundly immunosuppressed pediatric patient with Boerhaave syndrome. J Pediatr Hematol Oncol. 2005 Nov; 27(11):616-7.
    View in: PubMed
    Score: 0.001
  46. Nonmelanoma skin cancer in survivors of childhood and adolescent cancer: a report from the childhood cancer survivor study. J Clin Oncol. 2005 Jun 01; 23(16):3733-41.
    View in: PubMed
    Score: 0.001
  47. Psychological outcomes in long-term survivors of childhood brain cancer: a report from the childhood cancer survivor study. J Clin Oncol. 2004 Mar 15; 22(6):999-1006.
    View in: PubMed
    Score: 0.001
  48. Case series of thrombotic thrombocytopenic purpura in children and adolescents. J Pediatr Hematol Oncol. 2003 Apr; 25(4):336-9.
    View in: PubMed
    Score: 0.001
  49. Pancytopenia with chromosomal fragility: vitamin B12 deficiency. J Pediatr Hematol Oncol. 1996 May; 18(2):166-70.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.